The Drug-Induced Respiratory Disease Website

II - Myocardial dysfunction - Heart failure

II.d

Cardiovascular collapse - Cardiogenic shock - Hypotension

1

Evidence level

low

III - Myocardial ischemia - Coronary artery disease

III.c

Coronary vasospasm - Vasospastic angina

1

Evidence level

low

VI - Cardiomyopathy

VI.a

Cardiomyopathy (acute, subacute, chronic)

1

Evidence level

low

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)

2

Evidence level

possible

XI - Pulmonary vasculopathies

XI.a

Pulmonary arterial hypertension

1

Evidence level

low

XVI - Hemorrhage - Bleeding - Hematoma(s)

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)

1

Evidence level

low

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

1

Evidence level

low

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.d

Acute eosinophilic pneumonia (AEP)

1

Evidence level

low

XXVIII - Large airway involvement

XXVIII.a

Angioedema (may cause UAO, asphyxia and death)

1

Evidence level

low

XXXVIII - Miscellaneous - Varia

XXXVIII.d

Death following exposure or poisoning

2

Evidence level

possible